Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
exchanges : Nasdaq crawled date : 2022 - 11 - 01 save search
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS
Published: 2022-11-01 (Crawled : 23:00) - biospace.com/
CPIX | $1.61 -1.83% -1.86% 4.5K
|
Health Technology
|
| O: -5.6%
H: 9.38%
C: 8.99%
pharmaceuticals financial results
Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2022
Published: 2022-11-01 (Crawled : 23:00) - prnewswire.com
CHCT | $25.85 -0.42% 0.0% 90K
|
Finance
|
| O: 1.02%
H: 3.5%
C: 1.1%
trust
Silicon Motion Announces Results for the Period Ended September 30, 2022
Published: 2022-11-01 (Crawled : 23:00) - globenewswire.com
MXL 4 | $20.93 0.72% 0.72% 2.1M
|
Electronic Technology
|
| O: 1.08%
H: 3.4%
C: -2.11%
SIMO | $73.63 1.46% 1.44% 160K
|
Electronic Technology
|
| O: -3.73%
H: 12.83%
C: 7.49%
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
CRSP | News 4 | $55.66 -1.33% -1.35% 910K
|
Health Technology
|
| O: 2.81%
H: 0.63%
C: -3.33%
crispr therapeutics financial update results
TFF Pharmaceuticals Announces Second Patient Successfully Treated with Voriconazole Inhalation Powder Through Compassionate Use Program
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
TFFP | $3.04 2.36% 2.3% 13K
|
Health Technology
|
| O: 0.8%
H: 7.94%
C: 7.14%
pharmaceuticals program
Heron Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
HRTX M | $2.66 -5.0% -5.26% 2.2M
|
Health Technology
|
| O: 2.08%
H: 3.82%
C: -1.02%
report therapeutics financial results
Ligand Announces Completion of OmniAb Spin-Off
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -3.47%
Rigel Announces Top-line Results from FOCUS Phase 3 Clinical Trial of Fostamatinib in High Risk Hospitalized COVID-19 Patients
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
RIGL | $1.125 -1.32% -1.33% 6.4M
|
Health Technology
|
| O: 5.0%
H: 6.93%
C: -1.54%
covid-19 risk trial results
Cocrystal Pharma Granted European Patent Covering Oral Antiviral Candidate CC-42344 in Combination with Another Antiviral Agent for the Treatment of Influenza
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
COCP | $1.562 -1.39% 3.9K
|
Health Technology
|
| O: 4.03%
H: 0.78%
C: -4.65%
cc-4234 treatment pharma patent candidate antiviral granted influenza cc-42344
Novavax to Host Conference Call to Discuss Third Quarter 2022 Financial Results and Operational Highlights on November 8, 2022
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
NVAX | $4.15 -0.96% -0.96% 2.4M
|
Health Technology
|
| O: 2.92%
H: 10.38%
C: -4.01%
conference financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 1.18%
H: 4.35%
C: 0.32%
pharmaceuticals conference financial update results
First Round of Late-Breaking Clinical Trial Results Announced at VIVA22
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SRDX | $26.08 -3.12% -3.22% 63K
|
Health Technology
|
| O: -0.21%
H: 0.76%
C: -0.26%
viva22 trial results
LianBio Doses First Patient in Registrational Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 3.45%
H: 4.67%
C: -5.33%
TARS | $32.77 -2.79% -2.87% 320K
|
Health Technology
|
| O: 1.19%
H: 0.0%
C: -3.86%
tp-03 chinese trial
Arbutus Presents AB-729 Clinical Data and AB-101 Preclinical Data at AASLD - The Liver Meeting®
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
ASMB | $13.48 1.58% 1.56% 5.6K
|
Health Technology
|
| O: 2.44%
H: 1.19%
C: -1.79%
ABUS | $2.74 -0.36% -0.36% 340K
|
Health Technology
|
| O: 0.85%
H: 4.24%
C: 2.54%
ab-729 meeting liver preclinical ab-101
Ambrx Biopharma Inc. Appoints Daniel O’Connor as Chief Executive Officer
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
AMAM 4 | $28.0 0.0% 1.4M
|
Professional, Scientific, and T...
|
| O: -1.5%
H: 2.63%
C: -5.95%
ADXS | $0.54 12.48% 950
|
Health Technology
|
| O: 4.84%
H: 0.0%
C: -4.62%
biopharma
Anebulo Pharmaceuticals Announces Appointment of Nat Calloway, Ph.D., to Board of Directors
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
ANEB | $2.71 -7.14% 8.3K
|
Manufacturing
|
| O: 12.86%
H: 6.62%
C: 6.62%
pharmaceuticals
ViewRay Announces Third Quarter 2022 Results
Published: 2022-11-01 (Crawled : 22:00) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 2.27%
H: 1.78%
C: -4.0%
viewray results
Eloxx Pharmaceuticals Announces Opening of Clinical Trial Sites for Phase 2 Study of ELX-02 for the Treatment of Alport SyndromeTrial sites now open in Australia and the United Kingdom
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
ELOX | $0.825 -51.57% 93K
|
Health Technology
|
| O: 7.0%
H: 2.4%
C: -3.76%
elx-02 treatment pharmaceuticals australia trial study
Airbnb to Participate at Web Summit
Published: 2022-11-01 (Crawled : 22:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -2.99%
H: 0.0%
C: 0.0%
ABNB | $162.88 1.2% 1.18% 3.9M
|
Administrative and Support and ...
|
| O: -5.87%
H: 2.27%
C: -8.02%
Pan American Silver extends high-grade silver zone at the La Colorada Skarn project
Published: 2022-11-01 (Crawled : 22:00) - prnewswire.com
PAAS | $18.62 0.0% 2.1M
|
Non-Energy Minerals
|
| O: 0.61%
H: 1.07%
C: -5.96%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.